---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-089612"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2023-11-22T23:59:59+00:00"
generated_at: "2026-06-07T22:12:04.236551+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics adopts amended bylaws to strengthen shareholder proposal procedures

## Summary
- Board adopted Second Amended and Restated Bylaws on Nov 21, 2023, effective immediately.
- Amendments require enhanced disclosures from nominating shareholders, proposed nominees, and related persons.
- New provisions address Rule 14a-19 universal proxy and Rule 14a-8 shareholder proposals.
- Includes other ministerial, clarifying, and conforming changes.

## SEC filing metadata
- accession: 0001213900-23-089612
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2023-11-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000121390023089612/0001213900-23-089612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000121390023089612/ea188916-8k_intensity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-089612
- JSON: https://secwatch.observer/filing/0001213900-23-089612.json
- Plain text: https://secwatch.observer/filing/0001213900-23-089612.txt

## Key facts
- Governance Changes
  INTENSITY THERAPEUTICS, INC.: Board adopted second amended and restated bylaws effective immediately, enhancing procedural mechanics for shareholder nominations and making other updates (effective 2023-11-21).
  - Change: bylaw amendment
  - Effective: 2023-11-21
  source text: On November 21, 2023, the board of directors of Intensity Therapeutics, Inc. (the “Company”) adopted the second amended and restated bylaws (the “Second Amended and Restated Bylaws”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1567264/000121390023089612/0001213900-23-089612-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.